Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

After months of hesitation and years of planning the care.data initiative is finally set to launch soon.

The outcome of the May 7 vote is anticipated to be the hardest election to predict in recent memory.

The healthcare sector needs to celebrate its cyber successes if it’s to succeed in creating trust in a digitised system.

Cultural and behavioural change has been on the local government agenda for at least as long as my time spent…

If you were to ask any health and social care professional if they thought integration was a good idea then the…

Last week’s news that medical records have been sold when claiming insurance or purchasing medical products…

Today is Document Freedom Day. As of November 2012, all government bodies have had to adhere to Open Standards…

You’ve probably heard – you may even have begun to tire of the wall to wall coverage – but on…

Estimates suggest that 60-70% of total expenditure for a typical NHS organisation is dedicated to the employment…

Pressure on social care budgets is such that things simply can't continue being done as they have been in the past.

Our goal for health needs to change.We need to move away from the notion that health is the absence of disease…

Helping to set the EU regulatory framework, benefiting from EU funded R&D and the free movement of skilled engineers…